124 related articles for article (PubMed ID: 30134285)
1. Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases.
Shao G; Liu R; Ding W; Lu L; Li W; Cao H; Liu R; Li C; Xiang H; Yang Z; Yang J; Song J; Wang J
Anticancer Drugs; 2018 Nov; 29(10):1021-1025. PubMed ID: 30134285
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis.
Wei N; Zhang B; Wang Y; He XH; Xu LC; Li GD; Wang YH; Wang GZ; Huang HZ; Li WT
Clin Transl Oncol; 2019 Apr; 21(4):443-450. PubMed ID: 30306400
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
Ghiringhelli F; Vincent J; Bengrine L; Borg C; Jouve JL; Loffroy R; Guiu B; Blanc J; Bertaut A
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2357-2363. PubMed ID: 31273511
[TBL] [Abstract][Full Text] [Related]
4. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus.
Zhu LZ; Xu S; Qian HL
World J Gastroenterol; 2018 Jun; 24(23):2501-2507. PubMed ID: 29930471
[TBL] [Abstract][Full Text] [Related]
5. Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Zhao C; Fan L; Qi F; Ou S; Yu L; Yi X; Ni B; Zheng Z; Lu J; Zhang C; Chen C; Lu X; Cheng L; Hu T; Ma Y
Anticancer Drugs; 2016 Aug; 27(7):689-94. PubMed ID: 27145327
[TBL] [Abstract][Full Text] [Related]
6. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.
Albert M; Kiefer MV; Sun W; Haller D; Fraker DL; Tuite CM; Stavropoulos SW; Mondschein JI; Soulen MC
Cancer; 2011 Jan; 117(2):343-52. PubMed ID: 20830766
[TBL] [Abstract][Full Text] [Related]
7. Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.
Seitz JF; Bennouna J; Paillot B; Gamelin E; François E; Conroy T; Raoul JL; Becouarn Y; Bertheault-Cvitkovic F; Ychou M; Nasca S; Fandi A; Barthelemy P; Douillard JY
Ann Oncol; 2002 Jul; 13(7):1072-9. PubMed ID: 12176786
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
[TBL] [Abstract][Full Text] [Related]
9. Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.
Khouri C; Guiu B; Cercueil JP; Chauffert B; Ladoire S; Ghiringhelli F
Anticancer Drugs; 2010 Jul; 21(6):656-61. PubMed ID: 20216061
[TBL] [Abstract][Full Text] [Related]
10. A new chemoembolization protocol in refractory liver metastasis of colorectal cancer--a feasibility study.
Voigt W; Behrmann C; Schlueter A; Kegel T; Grothey A; Schmoll HJ
Onkologie; 2002 Apr; 25(2):158-64. PubMed ID: 12006767
[TBL] [Abstract][Full Text] [Related]
11. Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer.
Cortinovis D; Bajetta E; Di Bartolomeo M; Dognini G; Beretta E; Ferrario E; Ricotta R; Buzzoni R
Tumori; 2004; 90(2):186-91. PubMed ID: 15237580
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study.
Chen S; Zhang K; Liu W; Yu W
Eur J Cancer; 2020 Jul; 134():90-98. PubMed ID: 32497895
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
Larsen FO; Jensen BV; Nørgaard HH; Hermann HK; Larsen PN; Markussen A; Hogdall E; Nielsen D
Oncology; 2019; 96(6):299-308. PubMed ID: 30999314
[TBL] [Abstract][Full Text] [Related]
15. Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.
Vogl TJ; Jost A; Nour-Eldin NA; Mack MG; Zangos S; Naguib NN
Br J Cancer; 2012 Mar; 106(7):1274-9. PubMed ID: 22382689
[TBL] [Abstract][Full Text] [Related]
16. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
Scheithauer W; Kornek GV; Ulrich-Pur H; Penz M; Raderer M; Salek T; Haider K; Kwasny W; Depisch D
Cancer; 2001 Apr; 91(7):1264-71. PubMed ID: 11283925
[TBL] [Abstract][Full Text] [Related]
18. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S
Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
[TBL] [Abstract][Full Text] [Related]
20. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
Chen JX; Wileyto EP; Soulen MC
Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
